Botti C - Search Results

1

Contribution of fluorescence in situ hybridization to immunohistochemistry for the evaluation of HER-2 in breast cancer.

Cianciulli AM, Botti C, Coletta AM, Buglioni S, Marzano R, Benevolo M, Cione A, Mottolese M. Cianciulli AM, et al. Among authors: botti c. Cancer Genet Cytogenet. 2002 Feb;133(1):66-71. doi: 10.1016/s0165-4608(01)00559-3. Cancer Genet Cytogenet. 2002. PMID: 11890992

2

Breast cancer is associated with loss of the c-kit oncogene product.

Natali PG, Nicotra MR, Sures I, Mottolese M, Botti C, Ullrich A. Natali PG, et al. Among authors: botti c. Int J Cancer. 1992 Nov 11;52(5):713-7. doi: 10.1002/ijc.2910520508. Int J Cancer. 1992. PMID: 1385336

3

Changes in expression of alpha 6/beta 4 integrin heterodimer in primary and metastatic breast cancer.

Natali PG, Nicotra MR, Botti C, Mottolese M, Bigotti A, Segatto O. Natali PG, et al. Among authors: botti c. Br J Cancer. 1992 Aug;66(2):318-22. doi: 10.1038/bjc.1992.263. Br J Cancer. 1992. PMID: 1503905 Free PMC article.

4

DNA ploidy, cell kinetics, and epidermal growth factor receptor and HER2/neu oncoprotein expression in primary operable breast cancer.

d'Agnano I, Bucci B, Mottolese M, Benevolo M, Conti L, Botti C, Vecchione A, Casillo S, Zupi G. d'Agnano I, et al. Among authors: botti c. Ann N Y Acad Sci. 1996 Apr 30;784:472-81. doi: 10.1111/j.1749-6632.1996.tb16266.x. Ann N Y Acad Sci. 1996. PMID: 8651601 No abstract available.

5

Low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen-A2-positive breast cancer patients.

Nisticò P, Mottolese M, Mammi C, Benevolo M, Del Bello D, Rubiu O, Gentile FP, Botti C, Venturo I, Natali PG. Nisticò P, et al. Among authors: botti c. J Natl Cancer Inst. 1997 Feb 19;89(4):319-21. doi: 10.1093/jnci/89.4.319. J Natl Cancer Inst. 1997. PMID: 9048837 No abstract available.

6

EGF-R expression in ductal breast cancer: proliferation and prognostic implications.

Bucci B, D'Agnano I, Botti C, Mottolese M, Carico E, Zupi G, Vecchione A. Bucci B, et al. Among authors: botti c. Anticancer Res. 1997 Jan-Feb;17(1B):769-74. Anticancer Res. 1997. PMID: 9066618

7

Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.

Maini CL, Tofani A, Sciuto R, Semprebene A, Cavaliere R, Mottolese M, Benevolo M, Ferranti F, Grandinetti ML, Vici P, Lopez M, Botti C. Maini CL, et al. Among authors: botti c. J Nucl Med. 1997 Oct;38(10):1546-51. J Nucl Med. 1997. PMID: 9379190 Free article.

8

Aneusomy of chromosomes 1 and 17 in normal tissue adjacent to breast carcinomas.

Cianciulli AM, Pescatore B, Bovani R, Coletta AM, Gandolfo GM, Greco C, Botti C. Cianciulli AM, et al. Among authors: botti c. Eur J Histochem. 1997;41 Suppl 2:159-60. Eur J Histochem. 1997. PMID: 9859829 No abstract available.

9

Host immunosurveillance contributes to the control of erbB-2 overexpression in HLA-A2-breast-cancer patients.

Nisticò P, Mottolese M, Cascioli S, Benevolo M, Del Bello D, Di Modugno F, Rubiu O, Gentile FP, Botti C, Venturo I, Natali PG. Nisticò P, et al. Among authors: botti c. Int J Cancer. 1999 Dec 22;84(6):598-603. doi: 10.1002/(sici)1097-0215(19991222)84:6<598::aid-ijc10>3.0.co;2-7. Int J Cancer. 1999. PMID: 10567905

10

99Tcm-MIBI scintimammography in 300 consecutive patients: factors that may affect accuracy.

Tofani A, Sciuto R, Semprebene A, Festa A, Pasqualoni R, Giunta S, Mottolese M, Benevolo M, Botti C, Maini CL. Tofani A, et al. Among authors: botti c. Nucl Med Commun. 1999 Dec;20(12):1113-21. doi: 10.1097/00006231-199912000-00003. Nucl Med Commun. 1999. PMID: 10664992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters